Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes six lead clinical and preclinical drug candidates: mitazalimab (ADC-1013), ATOR-1015, ATOR-1017, ALG.APV-527 (co-developed with Aptevo Therapeutics Inc.), ATOR-1144 and AC101 (in clinical development by Shanghai Henlius Biotech Inc.).

52 Week, 6.88 - 25.52, Mkt Cap of share series 2, Month, -23.15. Year, 6.88 - Opening price, Market, First North GM Sweden, 6 month, -52.92. Vol. ICB Code

Each share entitles the holder to one vote at the Annual General Meeting. Here you find the latest stock price information regarding the Alligator Bioscience share. Senaste nyheter om - Alligator Bioscience, aktieanalys, kursutveckling och rapporter. Alligator Bioscience komplett bolagsfakta & börsnyheter från Analysguiden.

So we'll take a look at whether insiders have been buying or selling shares in Alligator Bioscience AB (publ) . Long term Alligator Bioscience AB (publ) shareholders know that all too well, since the share price is down considerably over three years. So they might be feeling emotional about the 65% share price collapse, in that time. The more recent news is of little comfort, with the share price down 21% in a year. Alligator Bioscience AB (publ) Securities: Shares (ISIN SE0000767188) Offering size: 12 923 077 shares: Offer price: SEK 32.50 per share: Ticker: ATORX: Stabilisation manager: Carnegie Investment Bank AB (publ) Alligator Bioscience håller tempot uppe 14 februari, 2020 Efter publiceringen av 2019 års resultat, kan marknaden konstatera att bioteknikbolaget Alligator Bioscience har kassa nog att driva utvecklingsarbetet framåt i planerad takt. Alligator Bioscience AB (publ) shareholders should be happy to see the share price up 17% in the last month.But the last three years have seen a terrible decline. The share price has sunk like a Because Alligator Bioscience hasn't been listed for many years, the market is still learning about how the business performs.

No results found. View more search results. 1 2 3 4 5 6 7 8 9 10

Alligator’s strategy is to develop the drugs to phase II and we believe there is a good probability of further deals, which given the size of recent deals, could be highly supportive for the valuation of Alligator. Acquisition values of similar stage immuno-oncology assets have ranged from USD 0.6bn to USD 0.9bn. Key Data (2018E) Price (SEK) Reuters Alligator Bioscience Insider Transactions Over The Last Year Over the last year, we can see that the biggest insider purchase was by Independent Director Jonas Sjögren for kr1.1m worth of shares Alligator Bioscience develops antibody-based pharmaceuticals for cancer treatment.

Alligator Bioscience AB (“Alligator” or the “Company”), a leading biotech company developing innovative immune activating antibody drugs for tumor-directed immunotherapy, announced on November 2, 2016 its intention to list the Company’s shares on Nasdaq Stockholm. Today, the Company publishes the prospectus for the offering (the “Offering”).

The latest Alligator Bioscience AB share price. View recent trades and share price information for Alligator Bioscience AB and other shares. Alligator Bioscience General Information Description. Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Feb 23, 2021 PRNewswire/ -- Last day of trading in BTA in Alligator Bioscience AB approximately SEK 86m before deduction of issue related costs. Shares are estimated to be delivered on the shareholders' account on March 4, Typical Price -- TECHNICAL INDICATORS -- Accumulation/Distribution Indicator Average True Range Chaikin Oscillator Chaikin's Volatility Commodity Channel Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed Stock Price $0.71. ALLIGATOR BIOSCIENCE (A2AN1Z | SE0000767188) mit aktuellem Aktienkurs, Charts, News und Analysen. Feb 24, 2021 Nasdaq Stockholm AB Equity Market information.
Dom javascript exercises

Alligator Bioscience is currently listed in the Small Cap segment. The number of ordinary shares is 71,388,615. Each share entitles the holder to one vote at the Annual General Meeting. ALLGF: Get the latest Alligator Bioscience stock price and detailed information including ALLGF news, historical charts and realtime prices. Cash Flow per Share-1.85 3.55 - Free Cash Flow -142 Latest Alligator Bioscience AB (ATORX:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Senaste nyheter om - Alligator Bioscience, aktieanalys, kursutveckling och rapporter. Alligator Bioscience komplett bolagsfakta & börsnyheter från Analysguiden. Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund Sweden Telefon: + 46 (0)46 540 82 00 info@alligatorbioscience.com ir@alligatorbioscience.com Alligator Bioscience AB is a Sweden-based company that is engaged in development of immunotherapies for the treatment of cancer. The Company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies.
Ringla keramik

Nov 23, 2016 On request of Alligator Bioscience AB, company registration number 556597- 8201, Nasdaq Stockholm AB has admitted the company's shares

The public information regarding Alligator Bioscience AB's current market price is not available at this time. Dr Peter Ellmark, VP Discovery, Alligator Bioscience will give an oral presentation with the title "Mitazalimab - a CD40 agonist to unleash CD40 in immuno-oncology" on November 5, 2020, at 12:50 p Alligator Bioscience develops antibody-based pharmaceuticals for cancer treatment. The Company is specialized in the development of tumor-targeted immunotherapies, particularly agonistic mono- and bispecific antibodies, and is engaged in the early stages of drug development, from the idea stage to clinical phase II trials.

Akustik_projekt pl

Alligator Bioscience has a market capitalisation of kr479m and burnt through kr181m last year, which is 38% of the company’s market value. That’s not insignificant, and if the company had to sell enough shares to fund another year’s growth at the current share price, you’d likely witness fairly costly dilution.

The Company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies.

Stock Market Sweden. From: 60 SEK / month The swedish major stock markets, except NGM. Svenska Börsen, Vill ALLIGATOR BIOSCIENCE. ALM EQUITY.

To wit the share price is down 54% in that time. Because Alligator Bioscience hasn't been listed for many years, the market is still learning about how the business performs.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. ATORX | Complete Alligator Bioscience AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.